DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Treon SP, Meid K, Hunter ZR. et al.
Phase 1 study of ibrutinib and the CXCR4 antagonist ulocuplumab in CXCR4-mutated Waldenström macroglobulinemia.
Blood 2021;
138 (17) 1535-1539
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.